Literature DB >> 30219805

Combined Pre- and Postoperative Lymphocyte Count Accurately Predicts Outcomes of Patients with Colorectal Cancer.

Manabu Yamamoto1, Hiroaki Saito2, Chihiro Uejima1, Akimitsu Tanio1, Seigo Takaya1, Keigo Ashida1, Yoshiyuki Fujiwara1.   

Abstract

BACKGROUND: Although preoperative lymphopenia is reportedly a prognostic factor in cancer patients, the association between postoperative lymphopenia and patient prognosis has not been widely studied.
METHODS: We enrolled 379 patients who underwent surgery for colorectal cancer (CRC) to analyze correlations among pre- and postoperative lymphocyte counts (LCs) and prognosis in patients with CRC.
RESULTS: Pre- and postoperative LCs were significantly correlated (r = 0.615, p < 0.0001). Based on results of receiver operating characteristic analysis, patients were subgrouped as preoperative LC ≥1,280 (pre-LCHigh, n = 234), preoperative LC < 1,280 (pre-LCLow, n = 145); and as postoperative LC ≥680 (post-LCHigh, n = 246), and postoperative LC < 680 (post-LCLow, n = 133). Five-year disease-specific survival rates significantly differed between pre-LCHigh (88.6%) and pre-LCLow (72.5%) groups (p < 0.0001); and also between the post-LCHigh (88.5%) and post-LCLow (71.1%) groups (p < 0.0001). Five-year disease-specific survival rates of patients who were both pre-LCLow and post-LCLow was significantly lower than those for patients who were either pre-LCHigh or post-LCHigh or pre-LCHigh/post-LCHigh (p = 0.0003). Multivariate analysis indicated that the combination of pre- and postoperative LC was an independent prognostic indicator.
CONCLUSIONS: The combination of pre- and postoperative LC is a predictive factor for prognosis in CRC patients.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Biomarker; Colorectal cancer; Lymphocyte; Prognosis; Recurrence

Mesh:

Year:  2018        PMID: 30219805     DOI: 10.1159/000492340

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  8 in total

1.  Inflammation-based Indexes Upon Adjuvant Chemotherapy Initiation as a Predictor of Relapse After Curative Resection of Colorectal Cancer With an Oxaliplatin-based Regimen.

Authors:  Masaya Satake; Kazuhiko Yoshimatsu; Masano Sagawa; Haijime Yokomizo; Shunichi Shiozawa
Journal:  Cancer Diagn Progn       Date:  2022-01-03

2.  Impact of the preoperative prognostic nutritional index on postoperative and survival outcomes in colorectal cancer patients who underwent primary tumor resection: a systematic review and meta-analysis.

Authors:  Guangwei Sun; Yalun Li; Yangjie Peng; Dapeng Lu; Fuqiang Zhang; Xueyang Cui; Qingyue Zhang; Zhuang Li
Journal:  Int J Colorectal Dis       Date:  2019-01-24       Impact factor: 2.571

3.  Combination of C-reactive Protein and Monocyte Count Is a Useful Prognostic Indicator for Patients With Colorectal Cancer.

Authors:  Manabu Yamamoto; Hiroaki Saito; Kazushi Hara; Ken Sugezawa; Chihiro Uejima; Akimitsu Tanio; Yoichiro Tada; Kyoichi Kihara; Teruhisa Sakamoto; Soichiro Honjo; Yoshiyuki Fujiwara
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

4.  Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer.

Authors:  Ying-Ying Zhang; Wan-Qing Li; Zhen-Fa Li; Xiao-Hua Guo; Shen-Kang Zhou; Aifen Lin; Wei-Hua Yan
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

5.  Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors.

Authors:  Juan Carlos Andreu-Ballester; Lorena Galindo-Regal; Julia Hidalgo-Coloma; Carmen Cuéllar; Carlos García-Ballesteros; Carolina Hurtado; Natalia Uribe; María Del Carmen Martín; Ana Isabel Jiménez; Francisca López-Chuliá; Antonio Llombart-Cussac
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

6.  Neutrophilia and post-radiation thrombocytopenia predict for poor prognosis in radiation-treated glioma patients.

Authors:  Eric J Hsu; Jamie Thomas; Elizabeth A Maher; Michael Youssef; Robert D Timmerman; Zabi Wardak; Minjae Lee; Tu D Dan; Toral R Patel; Dat T Vo
Journal:  Front Oncol       Date:  2022-09-09       Impact factor: 5.738

7.  The Prognostic Value of New Index (LANR) Composed of Pre-operative Lymphocytes, Albumin, and Neutrophils in Patients With Resectable Colorectal Cancer.

Authors:  Xinjun Liang; Shuang Yao; Ping Lu; Yifei Ma; Hongli Xu; Zhucheng Yin; Junjie Hu; Yanyan Liu; Shaozhong Wei
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

8.  Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics.

Authors:  Peiyun Long; Youya Zang; Huan Wang; Xiumei Liang; Xuekun Xie; Zhiwei Han; Dongyi Lin; Zongyu Wang; Shan Huang; Chuang Chen
Journal:  Onco Targets Ther       Date:  2020-03-09       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.